Correlation Between Fennec Pharmaceuticals and Viridian Therapeutics
Can any of the company-specific risk be diversified away by investing in both Fennec Pharmaceuticals and Viridian Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fennec Pharmaceuticals and Viridian Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Fennec Pharmaceuticals and Viridian Therapeutics, you can compare the effects of market volatilities on Fennec Pharmaceuticals and Viridian Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fennec Pharmaceuticals with a short position of Viridian Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fennec Pharmaceuticals and Viridian Therapeutics.
Diversification Opportunities for Fennec Pharmaceuticals and Viridian Therapeutics
-0.69 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Fennec and Viridian is -0.69. Overlapping area represents the amount of risk that can be diversified away by holding Fennec Pharmaceuticals and Viridian Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Viridian Therapeutics and Fennec Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fennec Pharmaceuticals are associated (or correlated) with Viridian Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Viridian Therapeutics has no effect on the direction of Fennec Pharmaceuticals i.e., Fennec Pharmaceuticals and Viridian Therapeutics go up and down completely randomly.
Pair Corralation between Fennec Pharmaceuticals and Viridian Therapeutics
Given the investment horizon of 90 days Fennec Pharmaceuticals is expected to generate 1.46 times more return on investment than Viridian Therapeutics. However, Fennec Pharmaceuticals is 1.46 times more volatile than Viridian Therapeutics. It trades about 0.17 of its potential returns per unit of risk. Viridian Therapeutics is currently generating about -0.1 per unit of risk. If you would invest 473.00 in Fennec Pharmaceuticals on August 27, 2024 and sell it today you would earn a total of 93.00 from holding Fennec Pharmaceuticals or generate 19.66% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Fennec Pharmaceuticals vs. Viridian Therapeutics
Performance |
| Timeline |
| Fennec Pharmaceuticals |
| Viridian Therapeutics |
Fennec Pharmaceuticals and Viridian Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Fennec Pharmaceuticals and Viridian Therapeutics
The main advantage of trading using opposite Fennec Pharmaceuticals and Viridian Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fennec Pharmaceuticals position performs unexpectedly, Viridian Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Viridian Therapeutics will offset losses from the drop in Viridian Therapeutics' long position.| Fennec Pharmaceuticals vs. Eliem Therapeutics | Fennec Pharmaceuticals vs. HCW Biologics | Fennec Pharmaceuticals vs. Scpharmaceuticals | Fennec Pharmaceuticals vs. Milestone Pharmaceuticals |
| Viridian Therapeutics vs. Nuvalent | Viridian Therapeutics vs. Arcellx | Viridian Therapeutics vs. Vaxcyte | Viridian Therapeutics vs. Crinetics Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Other Complementary Tools
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |